KITA Ayami (KITA Ayami)

写真a

Job title

Assistant Professor
To the head of this page.▲

Graduating School 【 display / non-display 】

  • Osaka University   Faculty of Pharmaceutical Science   薬科学科  Graduated 

To the head of this page.▲

Graduate School 【 display / non-display 】

  • Osaka University   Graduate School, Division of Pharmaceutical Sciences   創成薬学  Master's Course  Completed 

  • Osaka University   Graduate School, Division of Pharmaceutical Sciences   創成薬学  Doctor's Course  Completed 

To the head of this page.▲

Degree 【 display / non-display 】

  • Osaka University  -  修士（薬科学

  • Osaka University  -  博士（薬科学

To the head of this page.▲

Academic Society Affiliations 【 display / non-display 】

  • 日本ケミカルバイオロジー学会
  • 日本薬学会
To the head of this page.▲

Research field 【 display / non-display 】

  • Life Science / Molecular biology

To the head of this page.▲
 

Papers 【 display / non-display 】

  • Tomatidine attenuates post-stroke cognitive impairment by reducing neuroinflammation through prevention of M1 microglial polarization via NF-κB signaling

    Ayami Kita, Yuka Kawade, Haruyoshi Murakami, Rei Ikeda, Ryota Araki, Takeshi Yabe

    Journal of Pharmacological Sciences   2025.08

    Joint Work

    Research paper (scientific journal)

  • Decreased Brain pH Underlies Behavioral and Brain Abnormalities Induced by Chronic Exposure to Glucocorticoids in Mice

    Ryota Araki, Ayami Kita, Takeshi Yabe

    Biol Pharm Bull.   2024.11

    Joint Work

    Research paper (scientific journal)

  • Chronic corticosterone treatment decreases extracellular pH and increases lactate release via PDK4 upregulation in cultured astrocytes

    Kita A,Araki R,Yabe T

    Biol Pharm Bull.   2024.09

    Joint Work

    Research paper (scientific journal)

  • Chronic social defeat stress induces anxiety-like behaviors via downregulation of serotonin transporter in the prefrontal serotonergic system in mice.

    Araki R, Kita A, Ago Y, Yabe T.

    Neurochem Int.   2024.01

    Joint Work

  • 2´-fucosyllactose alleviates early weaning-induced anxiety-like behavior, amygdala hyperactivity, and gut microbiota changes.

    Araki R, Tominaga Y, Inoue R, Kita A, Yabe T.

    Biol Pharm Bull.   2023.04

    Joint Work

display all >>

To the head of this page.▲

Presentations 【 display / non-display 】

  • シロスタゾールはグルココルチコイドによる脳pH低下、うつ様行動、海馬神経新生の低下を軽減する

    日本薬学会第146年会  Japan  Domestic presentation  Poster presentation 

    2026.03
    　
    　

  • 幼若期クラリスロマイシン投与マウスの脳の異常における迷走神経の関与

    日本薬学会第146年会  Japan  Domestic presentation  Poster presentation 

    2026.03
    　
    　

  • 脳pH低下の軽減が中大脳動脈閉塞マウスの梗塞巣と運動機能障害に与える影響

    日本薬学会第146年会  Japan  Domestic presentation  Poster presentation 

    2026.03
    　
    　

  • ラット由来初代培養神経幹／前駆細胞の分化過程における遺伝子発現に細胞外pHの低下が及ぼす影響

    日本薬学会第146年会  Japan  Domestic presentation  Poster presentation 

    2026.03
    　
    　

  • グルココルチコイドによる脳pH低下を軽減する生薬の探索

    日本薬学会第146年会  Japan  Domestic presentation  Poster presentation 

    2026.03
    　
    　

display all >>

To the head of this page.▲